Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells

M. Towatari, H. Iida, M. Tanimoto, H. Iwata, M. Hamaguchi, H. Saito

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

Mitogen-activated protein (MAP) kinase appears to be one of the key regulators of cell proliferation and differentiation. Very little, however, has been revealed as to how MAP kinase is involved in leukemogenesis. We have studied the activation of the MAP kinase pathway in 100 human primary leukemia cells including 73 acute myelogenous leukemias (AMLs). Forty acute leukemia samples (40% of the total), including 37 AML samples (51% of AML), showed activation of MAP kinase as revealed by the mobility shift of the phosphorylated form of the protein and by in vitro kinase assay. This activation was correlated with MAP kinase kinase activity in these cells. In contrast, none of 14 chronic myelogenous leukemia samples showed the activation of MAP kinase. These results suggest that the MAP kinase pathway is constitutively activated in a subset of primary acute leukemias, and thus indicate the possible role of the constitutively activated MAP kinase in leukemogenesis.

Original languageEnglish
Pages (from-to)479-484
Number of pages6
JournalLeukemia
Volume11
Issue number4
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

Mitogen-Activated Protein Kinases
Leukemia
Acute Myeloid Leukemia
Mitogen-Activated Protein Kinase Kinases
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Cell Differentiation
Phosphotransferases
Cell Proliferation
Proteins

Keywords

  • AML
  • Human leukemia
  • MAP kinase
  • MAP kinase kinase
  • Phosphorylation

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this

Towatari, M., Iida, H., Tanimoto, M., Iwata, H., Hamaguchi, M., & Saito, H. (1997). Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells. Leukemia, 11(4), 479-484.

Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells. / Towatari, M.; Iida, H.; Tanimoto, M.; Iwata, H.; Hamaguchi, M.; Saito, H.

In: Leukemia, Vol. 11, No. 4, 1997, p. 479-484.

Research output: Contribution to journalArticle

Towatari, M, Iida, H, Tanimoto, M, Iwata, H, Hamaguchi, M & Saito, H 1997, 'Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells', Leukemia, vol. 11, no. 4, pp. 479-484.
Towatari M, Iida H, Tanimoto M, Iwata H, Hamaguchi M, Saito H. Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells. Leukemia. 1997;11(4):479-484.
Towatari, M. ; Iida, H. ; Tanimoto, M. ; Iwata, H. ; Hamaguchi, M. ; Saito, H. / Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells. In: Leukemia. 1997 ; Vol. 11, No. 4. pp. 479-484.
@article{66bdafdfb04e4c8aa9936c601001b19e,
title = "Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells",
abstract = "Mitogen-activated protein (MAP) kinase appears to be one of the key regulators of cell proliferation and differentiation. Very little, however, has been revealed as to how MAP kinase is involved in leukemogenesis. We have studied the activation of the MAP kinase pathway in 100 human primary leukemia cells including 73 acute myelogenous leukemias (AMLs). Forty acute leukemia samples (40{\%} of the total), including 37 AML samples (51{\%} of AML), showed activation of MAP kinase as revealed by the mobility shift of the phosphorylated form of the protein and by in vitro kinase assay. This activation was correlated with MAP kinase kinase activity in these cells. In contrast, none of 14 chronic myelogenous leukemia samples showed the activation of MAP kinase. These results suggest that the MAP kinase pathway is constitutively activated in a subset of primary acute leukemias, and thus indicate the possible role of the constitutively activated MAP kinase in leukemogenesis.",
keywords = "AML, Human leukemia, MAP kinase, MAP kinase kinase, Phosphorylation",
author = "M. Towatari and H. Iida and M. Tanimoto and H. Iwata and M. Hamaguchi and H. Saito",
year = "1997",
language = "English",
volume = "11",
pages = "479--484",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells

AU - Towatari, M.

AU - Iida, H.

AU - Tanimoto, M.

AU - Iwata, H.

AU - Hamaguchi, M.

AU - Saito, H.

PY - 1997

Y1 - 1997

N2 - Mitogen-activated protein (MAP) kinase appears to be one of the key regulators of cell proliferation and differentiation. Very little, however, has been revealed as to how MAP kinase is involved in leukemogenesis. We have studied the activation of the MAP kinase pathway in 100 human primary leukemia cells including 73 acute myelogenous leukemias (AMLs). Forty acute leukemia samples (40% of the total), including 37 AML samples (51% of AML), showed activation of MAP kinase as revealed by the mobility shift of the phosphorylated form of the protein and by in vitro kinase assay. This activation was correlated with MAP kinase kinase activity in these cells. In contrast, none of 14 chronic myelogenous leukemia samples showed the activation of MAP kinase. These results suggest that the MAP kinase pathway is constitutively activated in a subset of primary acute leukemias, and thus indicate the possible role of the constitutively activated MAP kinase in leukemogenesis.

AB - Mitogen-activated protein (MAP) kinase appears to be one of the key regulators of cell proliferation and differentiation. Very little, however, has been revealed as to how MAP kinase is involved in leukemogenesis. We have studied the activation of the MAP kinase pathway in 100 human primary leukemia cells including 73 acute myelogenous leukemias (AMLs). Forty acute leukemia samples (40% of the total), including 37 AML samples (51% of AML), showed activation of MAP kinase as revealed by the mobility shift of the phosphorylated form of the protein and by in vitro kinase assay. This activation was correlated with MAP kinase kinase activity in these cells. In contrast, none of 14 chronic myelogenous leukemia samples showed the activation of MAP kinase. These results suggest that the MAP kinase pathway is constitutively activated in a subset of primary acute leukemias, and thus indicate the possible role of the constitutively activated MAP kinase in leukemogenesis.

KW - AML

KW - Human leukemia

KW - MAP kinase

KW - MAP kinase kinase

KW - Phosphorylation

UR - http://www.scopus.com/inward/record.url?scp=0030972025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030972025&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 479

EP - 484

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 4

ER -